The fundamental treatment for NAFLD aims at addressing metabolic risk factors via weight loss through lifestyle interventions including diet and exercise.16 In recent studies diet and exercise have been shown to improve histology of the liver. A recommended diet of 1,200 kcal/day and moderate exercise for 60 min/day was shown to improve steatosis in a cohort study of highly motivated liver donors.17 High-intensity training, three times a week over 12 weeks, for 30-40 minutes was also shown to reduce hepatic steatosis.18 Furthermore, Vilar-Gomez et al found that NASH patients with a >5% weigh loss had a 58% reduction of NASH and patients who had a >10% weigh loss were shown a 90% resolution of NASH and 45% regression of fibrosis, however this was shown to have a minimal effect on glucose control. Other treatments that have been studied but have not been effective for example treatments of IR, drugs that induce weight loss, statins, cytoprotective agents and antioxidants, and blocker angiotensin receptor
The fundamental treatment for NAFLD aims at addressing metabolic risk factors via weight loss through lifestyle interventions including diet and exercise.16 In recent studies diet and exercise have been shown to improve histology of the liver. A recommended diet of 1,200 kcal/day and moderate exercise for 60 min/day was shown to improve steatosis in a cohort study of highly motivated liver donors.17 High-intensity training, three times a week over 12 weeks, for 30-40 minutes was also shown to reduce hepatic steatosis.18 Furthermore, Vilar-Gomez et al found that NASH patients with a >5% weigh loss had a 58% reduction of NASH and patients who had a >10% weigh loss were shown a 90% resolution of NASH and 45% regression of fibrosis, however this was shown to have a minimal effect on glucose control. Other treatments that have been studied but have not been effective for example treatments of IR, drugs that induce weight loss, statins, cytoprotective agents and antioxidants, and blocker angiotensin receptor